|
|
ASH 2011
The 53rd Annual Meeting of the American Society of Hematology (ASH) took place in San Diego, California December 10-13, 2011. The webcasts taped at the meeting are reports on the current status of some of the most interesting research in myeloma. Please be aware that at the time of posting, in some cases, the interviewees are reporting on interim data from incomplete clinical trials. Therefore not all the data presented are final results, and it is possible that results will be different when the data has matured with long-term follow-up. None of this research has yet been peer-reviewed and published in a medical journal.
|
|
|
|
|
Paul G. Richardson, MD
Dana-Farber Cancer Institute
Boston, Massachusetts, USA |
|
|
|
|
|
Jesús F San Miguel, MD PhD
Hospital Clinico Universitario
Salamanca, Spain |
|
|
|
|
|
Ruben Niesvizky, MD
Weill Cornell Medical College
New York, New York, USA
|
|
|
|
|
|
Ajay Nooka, MD, MPH, FACP
Winship Cancer Institute of Emory University
Atlanta, Georgia, USA
|
|
|
|
|
|
David S. Siegel, MD, PhD
Hackensack University Medical Center
Hackensack, New Jersey, USA |
|
|
|
|
|
María-Victoria Mateos, MD, PhD
Hospital Clinico Universitario
Salamanca, Spain |
|
|
|
|
|
Nikhil C. Munshi, MD
Dana-Farber Cancer Institute
Boston, Massachusetts, USA |
|
|
|
|
|
Ruben Niesvizky, MD
Weill Cornell Medical College
New York, New York, USA |
|
|
|
|
|
Heinz Ludwig, MD
Wilhelminenhospital
Vienna, Austria |
|
|
|
print
back to top